<DOC>
	<DOCNO>NCT03087227</DOCNO>
	<brief_summary>The use e-health improve quality health service rapidly expand research area , particular usefulness patient management home-hospital care pathway . Febrile neutropenia serious frequent complication cytotoxic chemotherapy good identification low-risk patient treat home could make possible technology . The objective study evaluate share health information system ( NEUTROSIS ) home-hospital management febrile neutropenia anti-tumor chemotherapy . The study aim compare average length hospital stay febrile neutropenia among patient receive NEUTROSIS receive standard care Materials methods A share information system ( NEUTROSIS ) develop connect smartphone web application patient exist share medical record Paris Sud hospital group ( AP-HP , France - 4D software ) . The study consist conduct randomize controlled trial compare cohort patient receive cytotoxic chemotherapy solid cancer heamatological malignancy use NEUTROSIS share information system ( n=100 ) cohort patient follow hospital 's standard care treatment period six month ( n=100 ) . During 15 day follow chemotherapy cycle , 2 group patient must take temperature daily . Both group train like patient chemotherapy contact team case fever . The NEUTROSIS group capture daily temperature occurrence symptom smartphone application . This information transmit instantly hospital care team alert case fever contact patient . The control group indicate data paper diary contact health team case fever do usual care . The two group patient follow 6 month questionnaire ask patient hospital visit chemotherapy cycle . The questionnaire collect information occurrence symptom healthcare use two chemotherapy cycle . A last follow-up questionnaire ask phone endpoint follow-up ( 6 month ) . The study take place two hospital site Paris University hospital ( A Béclère Kremlin-Bicètre ) .</brief_summary>
	<brief_title>Shared Health Information System Febrile Neutropenia</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Patient receive cytotoxic chemotherapy solid tumor hematological malignancy Patient sign consent participate study Patient able understand protocol care Patient cover health insurance Patient use smartphone tablet Internet connection patient refuse participate study patient participate drug trial patient receive shift weekly chemotherapy protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>mHealth</keyword>
	<keyword>febrile neutropenia</keyword>
	<keyword>neutropenia/chemically induced/*complications</keyword>
	<keyword>antineoplastic agents/*adverse event</keyword>
	<keyword>Patient readmission</keyword>
	<keyword>disease management</keyword>
</DOC>